** This course has been postponed.  Please check back for periodic updates. **

Managing the Metabolic Syndrome and Reducing the Risk of Coronary Disease: A Practical Approach

One in five – or 47 million - U.S. adults are affected by the metabolic syndrome, according to the American Heart Association (AHA). The metabolic syndrome, a combination of risk factors for coronary disease associated with being overweight and physically inactive, puts patients at a higher risk for developing diabetes as well as vascular disease. This is a growing concern for cardiologists and other internal medicine clinicians looking to understand the emerging data concerning the associations between the metabolic syndrome risk factors (obesity, high HDL, low LDL, high blood pressure and insulin resistance) and metabolic and cardiovascular consequences.

This CME symposium, Managing the Metabolic Syndrome and Reducing the Risk of Coronary Disease – A Practical Approach, will educate physicians and health care professionals on practical strategies in the management of the obese, insulin resistant patient with the metabolic syndrome. Understanding how to manage obesity and diabetes allows cardiologists and internal medicine physicians to monitor the management of these risk factors, which are so important in the prevention of coronary disease and coronary events. Participants will also benefit from learning the mechanisms of how obesity, diabetes, and the metabolic syndrome promote coronary vascular disease. They will also gain a fuller understanding of the latest approaches to management.

Attendees will have the opportunity to interact with the nationally recognized faculty in a personalized setting, as each session will end with a panel discussion featuring challenging case studies and interactive audience participation.

Educational Objectives:

Upon completion of this educational activity, the participant will be better able to:

• Assess the impact of metabolic syndrome and diabetes on the patient at risk for heart disease;
• Integrate new approaches to management of the metabolic issues in the diabetic and/or obese patient, especially those with cardiac disease
• Develop clinical approaches to treating lipids in the patient with diabetes and/or metabolic syndrome with an emphasis on both lifestyle change and combination drug therapy.